Roivant Sciences Ltd. · NASDAQ:ROIV
Manchester Keith S sold 1,638,163 Roivant Sciences Ltd. shares (Form 4)
Traded Jun 26 to Jun 30, 2026 · Filed Jun 30, 2026
From Jun 26 to Jun 30, 2026, Manchester Keith S (Director) sold 1,638,163 Roivant Sciences Ltd. shares at an average US$34.46 for US$56.4M, leaving 1,748,403 shares. Filed Jun 30, 2026 (Form 4).
- Sold
- 1,638,163 shares
- Price
- US$34.46 average (US$33.92 to US$35.45)
- Value
- US$56.4M
- Holding after
- 1,748,403 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 26, 2026 | Common Shares | Sale | 300,783 | US$33.92 | 14,826,546 | Indirect |
| Jun 26, 2026 | Common Shares | Sale | 325,000 | US$34.07 | 14,501,546 | Indirect |
| Jun 29, 2026 | Common Shares | Sale | 200,000 | US$34.44 | 14,301,546 | Indirect |
| Jun 29, 2026 | Common Shares | Sale | 600,000 | US$34.59 | 13,701,546 | Indirect |
| Jun 30, 2026 | Common Shares | Sale | 12,380 | US$35.28 | 13,689,166 | Indirect |
| Jun 30, 2026 | Common Shares | Sale | 200,000 | US$35.45 | 1,748,403 | Direct |